Assessment of quality of life in patients with bronchiectasis

Le résumé fourni par la source

Introduction: Bronchiectasis is a debilitating chronic lung disease with serious morbi-mortality. Recurrence of exacerbations is an important issue that considerably affects patients quality of life (QOL). We aimed to evaluate QOL and its determinant in bonchiectasis patients. Materials and methods: This was a prospective study including 50 patients with a confirmed diagnosis of non-cystic fibrosis bronchiectasis by computed tomography scan. All patients have not any other comorbidities. QOL was assessed using the Medical Outcomes Short Form-36 (SF-36), in stable patients. Eligible patients were divided into groups according to Lean cutoff value, equal to 66.7 Results: The mean age was 55 years old with a slight male predominance(54%). The chief complaints were dyspnea and sputum production. Mean BMI was25±3.9Kg/m2.Bronchectieasis was diffuse in 29patients with cylindrical and cystic forms predominance. Most common complication was bronchial infections(82%). Five patients were in chronic respiratory failure stage and 3 had chronic corpulmonale. Long term oxygen was indicated in10% of cases and NIV in 4%. The meanQOLscore was 64,4, withSF-36 physical component summary(PCS)score:65±20.8 and mental component summary(MCS)score:62±19.5. Poor QOL was found in 44% of the study population. The determinants of HRQOL in univariate study were: BMI(p=0.001)and number of hospitalizations(p=0.02). Neither BSI nor FACED scales were associated with QOL in bronchiectasis patients. Factors independently associated with QOL were BMI(p=0.08)and theophylline intake(p=0.04). Conclusion: SF-36 reflects an impaired QOL in bronchiectasis’s patients. SO, astratified approach to treatment is recommended in order to improve it.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.